How Big Pharma Is Turning Industrial Heat Into A Strategic Asset

AstraZeneca, Secaro, and ERM are launching a Clean Heat Program for pharmaceutical suppliers.

The initiative aims to replace fossil-fuel-based industrial heat with lower-carbon options such as biomethane.

Recent gas-price spikes have made heat costs and supply-chain risk more urgent for manufacturers.

The program targets hard-to-abate Scope 3 emissions while improving cost stability and resilience.